No abstract available
Publication types
-
Letter
-
Randomized Controlled Trial
-
Research Support, N.I.H., Extramural
MeSH terms
-
Anti-Bacterial Agents / therapeutic use
-
Azithromycin / therapeutic use
-
Disease Progression
-
Humans
-
Proportional Hazards Models
-
Pulmonary Disease, Chronic Obstructive / drug therapy
-
Pulmonary Disease, Chronic Obstructive / metabolism*
-
Receptors, Tumor Necrosis Factor, Type II / metabolism*
Substances
-
Anti-Bacterial Agents
-
Receptors, Tumor Necrosis Factor, Type II
-
TNFRSF1B protein, human
-
Azithromycin